Daxor Corporation DXR
Set alert
9.00 USD -0.14 -1.53%
As of Nov 2, 3:54 PM ET
8.90 Day range 9.19
8.40 52-week range 14.76
- YTD
- -38.98%
- 1 year
- -32.48%
- Open
- 9.19
- Prev close
- 9.14
- Mkt cap
- 52.54M
- Vol
- 3.68K
- Avg vol
- 19.98K
- EPS
- 1.10
- P/E
- 8.18
- Div yield
- 0.00%
More statistics
- Low
- 8.90
- High
- 9.19
- Forward P/E
- 0.00
- Beta
- -0.54
- Short ratio
- 0.60
- Inst. own
- 1.94%
- Dividend
- 0.00
- Ex-div date
- Jan 4, 2018
- Earnings
- Mar 28, 2012
- 50-d avg
- 8.96
- 200-d avg
- 9.04
- 1y target
- 23.38
2Y chart
Signals (112)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 6 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 20, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 12, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 18, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| RSI: Overbought | Dec 30, 2025 | 10 months ago |
| SMA: Bullish | Dec 23, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| RSI: Overbought | Sep 30, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 17, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 12, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 11, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 27, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 26, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 8, 2025 | 1 year ago |
| RSI: Overbought | Jun 23, 2025 | 1 year ago |
| RSI: Overbought | Jun 6, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 22, 2025 | 1 year ago |
| MACD: Buy Signal | May 16, 2025 | 1 year ago |
| MACD: Sell Signal | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | May 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 10, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 6, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 8, 2025 | 1 year ago |
Key statistics
- Market cap
- 40.17M
- Enterprise value
- 0
- Trailing P/E
- 7.16
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 260.51
- Price / book
- 1.23
- EPS (TTM)
- 1.16
- Beta
- -0.54
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1094.00%
- Revenue (TTM)
- 154.21K
- Revenue growth
- -11.40%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 1.65M
- Return on equity
- 5.35%
- Shares outstanding
- 4.84M
- Short % of float
- 0.71%
- 50-day average
- 8.96
- 200-day average
- 9.04
Analyst view
Consensus: none
Price target (mean) 23.38 +159.7% upside
Now 9.00
- Target (low)
- 22.00
- Target (mean)
- 23.38
- Target (high)
- 24.75
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 28, 2012
Expected Mar 28, 2012. Consensus EPS estimate 0.00.
Financials — quick view
DXR Revenue — quarterly 369.83K
DXR Net income — quarterly -1.49M
DXR EPS — quarterly -0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 28, 2012 | Dec 1, 2011 | 0.00 | — | — | — |
| Nov 14, 2011 | Sep 1, 2011 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jul 29, 2019 | Maxim Group | init | — | Buy |
| May 16, 2019 | Ascendiant Capital | init | — | Buy |
About Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- daxor.com
News
- Daxor Corporation (NASDAQ:DXR) Shares Shorted: Short Interest Down 51.5% in October
- Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
- Daxor Announces New Clinical Studies Validate BVA Technology In High-Acuity Heart Failure Populations To Enhance Care At HFSA 2026 Annual Scientific Meeting
- Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
- Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
- Daxor Corporation (NASDAQ:DXR) Sees Large Growth in Short Interest
- Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
- Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
- Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
- Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
Your note
Sign in to keep a note on DXR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FELDSCHUH JONATHAN ADAM | Officer and Director | Purchase | Dec 5, 2024 | 35,908 |
| FELDSCHUH MICHAEL RICHARD | Chief Executive Officer | Purchase | Dec 5, 2024 | 207,492 |
| FEUER EDWARD | Director | Purchase | Mar 3, 2024 | 1,000 |
| GOUDIE JOY S | Director | Purchase | May 23, 2023 | 300 |
| JOSEPH FELDSCHUH UEO | Trustee | Stock Gift | Sep 17, 2023 | 2,549,460 |
| MICHEL ROBERT J | Chief Financial Officer | Purchase | Mar 26, 2024 | 11,300 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.01% | 48,828 | 405.27K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.31% | 14,821 | 123.01K | Sep 29, 2024 |
| Keyes, Stange & Wooten Wealth Management, LLC | 0.30% | 14,612 | 121.28K | Sep 29, 2024 |
| Osaic Holdings Inc | 0.15% | 7,200 | 59.76K | Sep 29, 2024 |
| UBS Group AG | 0.03% | 1,236 | 10.26K | Sep 29, 2024 |
| Princeton Global Asset Management LLC | 0.01% | 500 | 4.15K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.01% | 48,828 | 405.27K | Sep 29, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.13% | 6,305 | 52.33K | Sep 29, 2024 |
| Gabelli Global Mini Mites Fund | 0.01% | 400 | 3.32K | Sep 29, 2024 |
| Northern Small Cap Core Fund | 0.00% | 37 | 307 | Sep 29, 2024 |